MALVERN, PA--(Marketwire - July 31, 2008) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended June 30, 2008. For the second quarter of 2008, Auxilium reported net revenues of $30.9 million compared to net revenues of $23.3 million in the second quarter of 2007.
